Table A1.
Demographic, clinical, and psychological characteristics.
| HC (N = 21) | ALS (N = 18) | Bayes Factor | ||||||
|---|---|---|---|---|---|---|---|---|
| Maximum | Mean | SD | n | Mean | SD | n | ||
| Age (years) | 57.67 | 9.16 | 21 | 58.11 | 10.05 | 18 | 0.32 | |
| Female [%] | 22% | 29% | 0.91 # | |||||
| Education (years) | 14.29 | 2.93 | 21 | 13.92 | 2.16 | 18 | 0.34 | |
| Disease Duration (months) | 50.47 | 82.93 | 17 | |||||
| FVC | 85.75 | 12.84 | 16 | |||||
| ESS | 24 | 6.12 | 3.06 | 17 | ||||
| ALSFRS-EX: total | 60 | 47.41 | 6.99 | 17 | ||||
| Bulbar Subscore | 16 | 13.94 | 1.89 | 17 | ||||
| Fine Motor Subscore | 16 | 11.41 | 2.87 | 17 | ||||
| Gross Motor Subscore | 16 | 11.12 | 5.02 | 17 | ||||
| Respiratory Subscore | 16 | 10.94 | 1.71 | 17 | ||||
| Progression Rate | 16 | 0.71 | 0.57 | 17 | ||||
| MoCA | 30 | 27.24 | 2.68 | 21 | 26.72 | 3.18 | 18 | 0.35 |
| FAB | 18 | 17.19 | 1.25 | 21 | 16.50 | 2.19 | 16 | 0.57 |
| ECAS: total | 136 | 104.38 | 11.58 | 21 | 103.89 | 12.19 | 18 | 0.32 |
| ECAS: ALS-Specific | 100 | 75.48 | 10.63 | 21 | 75.89 | 10.26 | 18 | 0.40 |
| Language | 28 | 26.62 | 1.94 | 21 | 25.94 | 2.13 | 18 | 0.48 |
| Fluency | 24 | 11.52 | 5.83 | 21 | 10.89 | 4.13 | 18 | 0.33 |
| Executive | 48 | 37.33 | 4.50 | 21 | 39.06 | 5.92 | 18 | 0.48 |
| ECAS: ALS-Nonspecific | 36 | 28.86 | 3.07 | 21 | 28.00 | 3.66 | 18 | 0.31 |
| Memory | 24 | 17.24 | 2.83 | 21 | 16.44 | 3.54 | 18 | 0.40 |
| Visuospatial | 12 | 11.62 | 0.74 | 21 | 11.56 | 0.62 | 18 | 0.32 |
Bayes factors were obtained from Bayesian independent samples t-tests. # Bayes factor was obtained from Bayesian contingency tables. All inferential statistics were carried out by means of JASP [106]. ALS = Amyotrophic lateral sclerosis patients; HC = healthy control participants; FVC = forced vital capacity; ESS = Epworth Sleepiness Scale [132]; ALSFRS-EX = Amyotrophic Lateral Sclerosis Functional Rating Scale—Self-Rating Scale [133]; MoCA = Montreal Cognitive Assessment [134]; FAB = Frontal Assessment Battery [135]; ECAS = Edinburgh Cognitive and Behavioural ALS Screen [117]; Please note that the present study utilized different WCST-based inclusion criteria for ALS patients and HC participants when compared to the initial publication of the data [15].